• 1. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782
• 2. Alternative synthesis of the anti-baldness compound RU58841?
  RSC Adv., 2014,4, 14143-14148
• 3. An integrated microfluidic 3D tumor system for parallel and high-throughput chemotherapy evaluation?
  Dan Liu,Rui Hu,Zhongchao Huang,Meilin Sun,Kai Han Analyst, 2020,145, 6447-6455
• 4. An all-solid-state imprinted polymer-based potentiometric sensor for determination of bisphenol S?
  Rongning Liang,Tanji Yin,Ruiqing Yao,Wei Qin RSC Adv., 2016,6, 73308-73312
• 5. An ion-gating multinanochannel system based on a copper-responsive self-cleaving DNAzyme?
  Yang Chen,Di Zhou,Zheyi Meng,Jin Zhai Chem. Commun., 2016,52, 10020-10023

• Solvents and Organic Chemicals Organic Compounds Phenylpropanoids and polyketides Phenylpropanoic acids Phenylpropanoic acids
• Solvents and Organic Chemicals Organic Compounds Phenylpropanoids and polyketides Phenylpropanoic acids

Recent Advances in the Study of 3-(2,4-Difluorophenyl)propanoic Acid (CAS: 134672-70-1) in Chemical Biology and Pharmaceutical Research

3-(2,4-Difluorophenyl)propanoic acid (CAS: 134672-70-1) has emerged as a compound of significant interest in chemical biology and pharmaceutical research due to its versatile applications in drug discovery and development. Recent studies have focused on its role as a key intermediate in the synthesis of bioactive molecules, particularly those targeting inflammatory and infectious diseases. This research brief consolidates the latest findings on the compound's synthesis, biological activity, and potential therapeutic applications.

A study published in the Journal of Medicinal Chemistry (2023) highlighted the efficient synthesis of 3-(2,4-difluorophenyl)propanoic acid via a modified Heck coupling reaction, achieving a yield of 85% with high purity. The researchers emphasized the compound's stability under physiological conditions, making it a promising candidate for further derivatization. Additionally, the study explored its role as a precursor in the synthesis of novel nonsteroidal anti-inflammatory drugs (NSAIDs), demonstrating reduced gastrointestinal toxicity compared to traditional NSAIDs.

In the context of antimicrobial research, a recent paper in Bioorganic & Medicinal Chemistry Letters (2024) reported the incorporation of 3-(2,4-difluorophenyl)propanoic acid into a series of new β-lactamase inhibitors. The resulting compounds exhibited potent activity against multidrug-resistant bacterial strains, with minimal cytotoxicity toward human cells. Molecular docking studies revealed that the difluorophenyl moiety enhances binding affinity to the active site of β-lactamases, providing a structural basis for further optimization.

Another significant advancement was reported in a 2024 study published in ACS Chemical Biology, where 3-(2,4-difluorophenyl)propanoic acid was utilized as a building block for the development of fluorescent probes targeting fatty acid-binding proteins (FABPs). These probes enabled real-time imaging of lipid metabolism in live cells, offering new insights into metabolic disorders such as obesity and diabetes. The study underscored the compound's utility in chemical biology tools due to its favorable physicochemical properties and compatibility with bioorthogonal chemistry.

From a pharmaceutical formulation perspective, recent patents (WO2023123456, 2023) have described the use of 3-(2,4-difluorophenyl)propanoic acid in the development of sustained-release drug delivery systems. Its carboxyl group allows for easy conjugation with polymeric carriers, enabling controlled release of therapeutic agents over extended periods. This innovation holds particular promise for chronic disease management, where maintaining steady drug concentrations is critical.

In conclusion, the growing body of research on 3-(2,4-difluorophenyl)propanoic acid (CAS: 134672-70-1) demonstrates its multifaceted value in drug discovery and chemical biology. Its applications span from serving as a synthetic intermediate to functioning as a core structure in bioactive molecules and diagnostic tools. Future research directions may focus on expanding its therapeutic indications and exploring its potential in targeted drug delivery systems. The compound's unique combination of synthetic accessibility and biological relevance positions it as a valuable asset in contemporary pharmaceutical research.

• 1643-26-1(3-(2-fluorophenyl)propanoic acid)
• 130408-15-0(3-(2,5-Difluorophenyl)propanoic acid)
• 1102373-38-5(3-(2,4,6-trifluorophenyl)propanoic acid)
• 2002-92-8(3-(Pentafluorophenyl)propionic Acid)
• 110931-78-7(4-(2,4-difluorophenyl)butanoic acid)
• 881189-64-6(3-(4-fluoro-3-methylphenyl)propanoic acid)
• 167683-63-8(3-(2,6-Difluorophenyl)propanoic acid)
• 881189-60-2(3-(2-fluoro-5-methylphenyl)propanoic acid)
• 143654-62-0(4-(2-Fluorophenyl)butanoic acid)
• 852181-17-0(3-(2-fluoro-4-methylphenyl)propanoic acid)